Viridian Therapeutic (VRDN) PT Raised to $43 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
Form 8-K Viridian Therapeutics, For: Jun 26
June 29, 2026 6:02 AM EDTViridian Therapeutics, Inc.\DE false 0001590750 0001590750... More
Form SCHEDULE 13G Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
June 26, 2026 4:05 PM EDThtml,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td { margin: 0; padding: 0; border: 0; outline: 0; font-weight: inherit; font-style: inherit; font-size: 100%; font-family: inherit; vertical-align: baseline; } :focus { outline: 0; } body { line-height: 1; color: black; background: white; } .fakeBox { border-top: 1px solid #999; border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; border-left: 2px solid #999; padding: 0px; min-width:... More



